Physician profile
Karen E Lanier
NPI 1528160959
$3,400.11
in general payments reported to CMS, 2019-2025
11 companies · $63.58 in 2025
The $63.58 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $203 · 2021: $2,321 · 2022: $171 · 2023: $44.67 · 2024: $156 · 2025: $63.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strategic Dentistry LLC | $2,199.00 | 2021 | |
| Nobel Biocare USA | $303.22 | 2019-2023 | Nobelactive |
| Dentsply Sirona INC | $176.58 | 2019-2025 | Atlantis |
| Zimmer Biomet Holdings, INC. | $172.37 | 2019-2021 | |
| Zimvie INC. | $135.93 | 2022-2024 | |
| Dentsply Ih INC. | $127.57 | 2019 | |
| Straumann USA LLC | $94.64 | 2020-2025 | |
| Geistlich Pharma, North America, INC. | $85.73 | 2024 | Geistlich Bio-Gide |
| Patterson Companies, INC. | $65.37 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $26.04 | 2022-2024 | Ossix Plus, Arestin |
| Philips North America LLC | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Lanier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.